Gardner Russo & Quinn’s AbbVie ABBV Stock Holding History

Gardner Russo & Quinn’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.12M	Hold	12,410	–	–	0.04%	30
2026 Q1	$2.7M	Hold	12,410	–	–	0.03%	30
2025 Q4	$2.84M	Hold	12,410	–	–	0.03%	31
2025 Q3	$2.87M	Hold	12,410	–	–	0.03%	31
2025 Q2	$2.3M	Hold	12,410	–	–	0.02%	34
2025 Q1	$2.6M	Hold	12,410	–	–	0.03%	33
2024 Q4	$2.21M	Sell	12,410 -100	-0.8%	-$18.4K	0.02%	35
2024 Q3	$2.47M	Hold	12,510	–	–	0.03%	39
2024 Q2	$2.15M	Hold	12,510	–	–	0.02%	42
2024 Q1	$2.28M	Hold	12,510	–	–	0.02%	40
2023 Q4	$1.94M	Sell	12,510 -73	-0.6%	-$10.6K	0.02%	45
2023 Q3	$1.88M	Sell	12,583 -8	-0.1%	-$1.17K	0.02%	43
2023 Q2	$1.7M	Sell	12,591 -19	-0.2%	-$2.79K	0.02%	44
2023 Q1	$2.01M	Hold	12,610	–	–	0.02%	45
2022 Q4	$2.04M	Hold	12,610	–	–	0.02%	43
2022 Q3	$1.69M	Hold	12,610	–	–	0.02%	48
2022 Q2	$1.93M	Sell	12,610 -300	-2%	-$45.8K	0.02%	47
2022 Q1	$2.09M	Hold	12,910	–	–	0.02%	49
2021 Q4	$1.75M	Hold	12,910	–	–	0.02%	51
2021 Q3	$1.39M	Buy	12,910 +300	+2%	+$34.3K	0.01%	56
2021 Q2	$1.42M	Hold	12,610	–	–	0.01%	55
2021 Q1	$1.36M	Hold	12,610	–	–	0.01%	55
2020 Q4	$1.35M	Hold	12,610	–	–	0.01%	55
2020 Q3	$1.1M	Buy	12,610 +16	+0.1%	+$1.51K	0.01%	56
2020 Q2	$1.24M	Buy	12,594 +84	+0.7%	+$7.4K	0.01%	53
2020 Q1	$953K	Sell	12,510 -300	-2%	-$25.6K	0.01%	58
2019 Q4	$1.13M	Sell	12,810 -200	-2%	-$16.6K	0.01%	57
2019 Q3	$985K	Hold	13,010	–	–	0.01%	61
2019 Q2	$946K	Hold	13,010	–	–	0.01%	61
2019 Q1	$1.05M	Sell	13,010 -956	-7%	-$78.2K	0.01%	60
2018 Q4	$1.29M	Hold	13,966	–	–	0.01%	53
2018 Q3	$1.32M	Hold	13,966	–	–	0.01%	56
2018 Q2	$1.29M	Buy	13,966 +266	+2%	+$26K	0.01%	60
2018 Q1	$1.3M	Sell	13,700 -400	-3%	-$43.9K	0.01%	62
2017 Q4	$1.36M	Sell	14,100 -3,700	-21%	-$349K	0.01%	63
2017 Q3	$1.58M	Buy	17,800 +1,600	+10%	+$122K	0.01%	62
2017 Q2	$1.18M	Hold	16,200	–	–	0.01%	64
2017 Q1	$1.06M	Sell	16,200 -906	-5%	-$57K	0.01%	66
2016 Q4	$1.07M	Hold	17,106	–	–	0.01%	67
2016 Q3	$1.08M	Hold	17,106	–	–	0.01%	69
2016 Q2	$1.06M	Sell	17,106 -4,612	-21%	-$281K	0.01%	68
2016 Q1	$1.24M	Sell	21,718 -65,000	-75%	-$3.62M	0.01%	64
2015 Q4	$5.14M	Hold	86,718	–	–	0.04%	36
2015 Q3	$4.72M	Hold	86,718	–	–	0.04%	37
2015 Q2	$5.83M	Hold	86,718	–	–	0.05%	37
2015 Q1	$5.08M	Hold	86,718	–	–	0.05%	36
2014 Q4	$5.67M	Sell	86,718 -59	-0.1%	-$3.72K	0.05%	36
2014 Q3	$5.01M	Hold	86,777	–	–	0.05%	40
2014 Q2	$4.9M	Hold	86,777	–	–	0.05%	41
2014 Q1	$4.46M	Hold	86,777	–	–	0.04%	41
2013 Q4	$4.58M	Hold	86,777	–	–	0.05%	42
2013 Q3	$3.88M	Sell	86,777 -350	-0.4%	-$15.5K	0.04%	43
2013 Q2	$3.6M	Buy	+87,127	New	+$3.81M	0.04%	43

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Gardner Russo & Quinn's ABBV Position: Q2 2026 in Review

Gardner Russo & Quinn held its AbbVie (ABBV) position steady in Q2 2026 at 12,410 shares worth $3.12M. The position accounts for 0.04% of the portfolio, ranked #30.

Gardner Russo & Quinn first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.83M in Q2 2015. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Gardner Russo & Quinn held 12,410 shares of AbbVie worth $3.12M as of Q2 2026.
Gardner Russo & Quinn left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.04% of Gardner Russo & Quinn's portfolio in Q2 2026, its #30 holding.
Gardner Russo & Quinn first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
Gardner Russo & Quinn's AbbVie position peaked at $5.83M in Q2 2015.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Gardner Russo & Quinn's 13F filing for Q2 2026, filed 13 Aug 2026.